- Home
- FPAY vs NRXP Comparison
FPAY vs NRXP Comparison
Compare FPAY & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FPAY
- NRXP
- Stock Information
- Founded
- FPAY 2003
- NRXP 2015
- Country
- FPAY United States
- NRXP United States
- Employees
- FPAY N/A
- NRXP N/A
- Industry
- FPAY Diversified Commercial Services
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- FPAY Consumer Discretionary
- NRXP Health Care
- Exchange
- FPAY Nasdaq
- NRXP Nasdaq
- Market Cap
- FPAY 28.7M
- NRXP 32.6M
- IPO Year
- FPAY N/A
- NRXP N/A
- Fundamental
- Price
- FPAY $1.36
- NRXP $3.16
- Analyst Decision
- FPAY Strong Buy
- NRXP Strong Buy
- Analyst Count
- FPAY 2
- NRXP 4
- Target Price
- FPAY $3.25
- NRXP $28.50
- AVG Volume (30 Days)
- FPAY 42.2K
- NRXP 392.0K
- Earning Date
- FPAY 08-05-2025
- NRXP 05-15-2025
- Dividend Yield
- FPAY N/A
- NRXP N/A
- EPS Growth
- FPAY N/A
- NRXP N/A
- EPS
- FPAY N/A
- NRXP N/A
- Revenue
- FPAY $139,800,732.00
- NRXP N/A
- Revenue This Year
- FPAY $16.58
- NRXP N/A
- Revenue Next Year
- FPAY N/A
- NRXP N/A
- P/E Ratio
- FPAY N/A
- NRXP N/A
- Revenue Growth
- FPAY 19.51
- NRXP N/A
- 52 Week Low
- FPAY $0.97
- NRXP $1.10
- 52 Week High
- FPAY $2.37
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- FPAY 55.04
- NRXP 75.25
- Support Level
- FPAY $1.36
- NRXP $2.55
- Resistance Level
- FPAY $1.44
- NRXP $2.72
- Average True Range (ATR)
- FPAY 0.08
- NRXP 0.24
- MACD
- FPAY 0.01
- NRXP 0.04
- Stochastic Oscillator
- FPAY 75.00
- NRXP 98.58
About FPAY FlexShopper Inc.
FlexShopper Inc is a financial technology company engaged in providing certain types of durable goods to consumers on a lease-to-own basis and providing lease-to-own (LTO) terms to consumers of third-party retailers and e-tailers. Its products include electronics, computers, furniture, mattresses, cameras and camcorders, audio, musical instruments, health, fitness and sports, video games, homes, gardens and tools, appliances, and vacuums on a payment, lease basis. The firm generates a majority of its revenue by leasing its products. The company enables consumers utilizing its e-commerce marketplace to shop for brand-name electronics, home furnishings, and other durable goods on a lease-to-own (LTO) basis.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.